drugset / Trial / NCT05756179

Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis

NCT05756179

Phase 3 Recruiting 80 enrolled Alexandria University
RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis

Timeline

Start
2023-07-18
Primary completion
2025-09
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diosmin Small molecule 450 mg
Comparator Hesperidin Small molecule 50 mg

Indications